TerrAscend Raises Guidance For 2020 Sales Again

TerrAscend Corp.(OTCQX: TRSSF) announced preliminary financial results for its fourth quarter and full-year ending December 31, 2020. The fourth-quarter net sales grew 28% sequentially to $65 million and 152% year-over-year. TerrAscend said it will host a scheduled conference call to discuss its 2020 results and provide updated 2021 guidance on March 23rd, 2021.

“Our fourth-quarter results demonstrate robust sequential revenue growth and continued expansion of EBITDA margins, which reflect the strong fundamentals of our business,” said Jason Ackerman, CEO and Executive Chairman of TerrAscend. “During the quarter, we realized sales from key expansion projects in Pennsylvania, New Jersey, and California, that together with our pending entrance into the Maryland market, position the company for continued growth in 2021.”

The company is estimating that full-year net sales will be $198 million and adjusted EBITDA will be $60 million. This is more than what the company had guided in November when TerrAscend said it was increasing its full-year 2020 guidance to at least $196 million in net sales and at least $54 million of adjusted EBITDA. At that time, the company said its outlook was driven by its emphasis on organic growth through expansion in high-quality, limited license markets while continuing to maintain tight control on costs. TerrAscend’s sales and profits in Pennsylvania are expected to continue to scale following its recently completed 25% cultivation expansion. In New Jersey, sales from the company’s greenhouse and indoor cultivation facilities began in November and are expected to ramp throughout 2021.


TerrAscend reiterated its 2021 guidance for net sales of $360-380 million and adjusted EBITDA of $140-160 million.

In November Ackerman said, “We continued to build out our footprint in the northeast, including completion of an additional 25% cultivation expansion at our Pennsylvania facility in Q3, which began selling into the market in November. In New Jersey, where I believe we will be a major player, sales from our newly operational cultivation facility and our first retail location in Phillipsburg are expected to begin in the coming days. I look forward to realizing the full benefit of our substantially larger cultivation and manufacturing capacities across our system, including our recently announced Maryland acquisition, to further accelerate our revenue and adjusted EBITDA growth in Q4 and beyond.”

Debra Borchardt

Debra Borchardt is the CEO, Co-Founder, and Editor-In-Chief of GMR. She has covered the cannabis industry for several years at Forbes, Seeking Alpha and TheStreet. Prior to becoming a financial journalist, Debra was a Vice President at Bear Stearns where she held a Series 7 and Registered Investment Advisor license. Debra has a Masters degree in Business Journalism from New York University.

One comment

  • Craig Simpson

    February 25, 2021 at 8:40 am

    Interesting. If you want to maximize your sales forecast, it most depends on your personal sales efforts. He must constantly monitor that his employees fulfill the forecasts for their clients. Here the rule is “no more than one sequential technique” If the client paid on the appointed day, good. If not, nobody cares about talking about the client’s objective difficulties. The employee himself must tell the sales manager the time (short!) For which he will bring this deal to a result. If the deadline has passed, but there is no result, the manager takes over the deal. For the appropriate remuneration.


Leave a Reply

Your email address will not be published. Required fields are marked *

Don't Miss This Week's Groundbreaking News

Join the thousands of subscribers who stay informed with GMR's exclusive news briefs delivered directly to your inbox every Friday afternoon.

We respect your privacy. See our privacy policy.

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


Recent Tweets

@GreenMarketRpt – 2 days

New Report from ⁦@headset_io⁩ Says Medical Cannabis Consumers Spend More. New story from ⁦@julsaitch⁩

@GreenMarketRpt – 2 days

Yowza. Be careful when investing in crowdfunding deals. SEC files complaint against CEO and others for…

Back to Top